Cytokinetics Inc. buy Truist Financial Co.
Start price
08.04.24
/
50%
€68.00
Target price
08.04.25
€79.21
Performance (%)
-53.24%
End price
09.04.25
€31.80
Summary
This prediction ended on 09.04.25 with a price of €31.80. The BUY prediction by Truist_Financial_Co_ for Cytokinetics Inc. performed very badly with a performance of -53.24%. Truist_Financial_Co_ has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -4.448% | -4.448% | 62.047% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $86.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€56.50
03.02.26
03.02.26
€77.92
03.02.27
03.02.27
-1.91%
10.04.26
10.04.26
Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.00
29.05.24
29.05.24
€64.57
29.05.25
29.05.25
-40.00%
30.05.25
30.05.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€76.00
28.12.23
28.12.23
€77.64
28.12.24
28.12.24
-41.05%
29.12.24
29.12.24